发明申请
- 专利标题: AMPHETAMINE CONTROLLED RELEASE, PRODRUG, AND ABUSE-DETERRENT DOSAGE FORMS
-
申请号: US15441424申请日: 2017-02-24
-
公开(公告)号: US20180243241A1公开(公告)日: 2018-08-30
- 发明人: Karl Popp , Harold Meckler
- 申请人: CHEMAPOTHECA, LLC
- 主分类号: A61K31/137
- IPC分类号: A61K31/137 ; A61K9/20 ; A61K9/00 ; A61K9/48
摘要:
The invention also relates to pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.
公开/授权文献
信息查询